182 related articles for article (PubMed ID: 3081686)
1. Characterization of sodium-dependent [3H]GBR-12935 binding in brain: a radioligand for selective labelling of the dopamine transport complex.
Janowsky A; Berger P; Vocci F; Labarca R; Skolnick P; Paul SM
J Neurochem; 1986 Apr; 46(4):1272-6. PubMed ID: 3081686
[TBL] [Abstract][Full Text] [Related]
2. Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935.
Berger SP; Martenson RE; Laing P; Thurkauf A; Decosta B; Rice KC; Paul SM
Mol Pharmacol; 1991 Apr; 39(4):429-35. PubMed ID: 2017146
[TBL] [Abstract][Full Text] [Related]
3. Quantitative autoradiography of the dopamine uptake complex in rat brain using [3H]GBR 12935: binding characteristics.
Richfield EK
Brain Res; 1991 Feb; 540(1-2):1-13. PubMed ID: 1829013
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of [3H]GBR 12935 binding in the human and rat frontal cortex.
Hitri A; Venable D; Nguyen HQ; Casanova MF; Kleinman JE; Wyatt RJ
J Neurochem; 1991 May; 56(5):1663-72. PubMed ID: 1901595
[TBL] [Abstract][Full Text] [Related]
5. High-affinity [3H]GBR 12783 binding to a specific site associated with the neuronal dopamine uptake complex in the central nervous system.
Bonnet JJ; Protais P; Chagraoui A; Costentin J
Eur J Pharmacol; 1986 Jul; 126(3):211-22. PubMed ID: 3489625
[TBL] [Abstract][Full Text] [Related]
6. Characterization of binding of [3H]GBR 12935 (1-[2-(diphenylmethoxy)ethyl]-4-(3-phenylpropyl)-piperazine) to membranes and to solubilized membrane extracts from terminal field regions of mesolimbic, mesocortical and nigrostriatal dopamine pathways.
Izenwasser S; Werling LL; Rosenberger JG; Cox BM
Neuropharmacology; 1990 Nov; 29(11):1017-24. PubMed ID: 2087254
[TBL] [Abstract][Full Text] [Related]
7. [3H]GBR 12935 binding to human platelet membranes is sensitive to piperazine derivatives but not to dopamine uptake inhibitors.
Gordon I; Weizman R; Rehavi M
Life Sci; 1994; 55(3):189-99. PubMed ID: 8007761
[TBL] [Abstract][Full Text] [Related]
8. [3H]GBR-12935 binding to the dopamine transporter is decreased in the caudate nucleus in Parkinson's disease.
Janowsky A; Vocci F; Berger P; Angel I; Zelnik N; Kleinman JE; Skolnick P; Paul SM
J Neurochem; 1987 Aug; 49(2):617-21. PubMed ID: 3598589
[TBL] [Abstract][Full Text] [Related]
9. Imaging the dopamine uptake site with ex vivo [18F]GBR 13119 binding autoradiography in rat brain.
Ciliax BJ; Kilbourn MR; Haka MS; Penney JB
J Neurochem; 1990 Aug; 55(2):619-23. PubMed ID: 2115074
[TBL] [Abstract][Full Text] [Related]
10. [3H]Threo-(+/-)-methylphenidate binding to 3,4-dihydroxyphenylethylamine uptake sites in corpus striatum: correlation with the stimulant properties of ritalinic acid esters.
Schweri MM; Skolnick P; Rafferty MF; Rice KC; Janowsky AJ; Paul SM
J Neurochem; 1985 Oct; 45(4):1062-70. PubMed ID: 4031878
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex.
Andersen PH
J Neurochem; 1987 Jun; 48(6):1887-96. PubMed ID: 2952763
[TBL] [Abstract][Full Text] [Related]
12. Interaction of [3H]GBR 12935 and GBR 12909 with the dopamine uptake complex in nucleus accumbens.
Berger P; Elsworth JD; Arroyo J; Roth RH
Eur J Pharmacol; 1990 Feb; 177(1-2):91-4. PubMed ID: 1967129
[TBL] [Abstract][Full Text] [Related]
13. In vivo binding of [3H]GBR 12783, a selective dopamine uptake inhibitor, in mouse striatum.
Chagraoui A; Bonnet JJ; Protais P; Costentin J
Neurosci Lett; 1987 Jul; 78(2):175-9. PubMed ID: 3627558
[TBL] [Abstract][Full Text] [Related]
14. The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins.
Niznik HB; Tyndale RF; Sallee FR; Gonzalez FJ; Hardwick JP; Inaba T; Kalow W
Arch Biochem Biophys; 1990 Feb; 276(2):424-32. PubMed ID: 2306106
[TBL] [Abstract][Full Text] [Related]
15. In vivo labelling of the neuronal dopamine uptake complex in the mouse striatum by [3H]GBR 12783.
Vaugeois JM; Bonnet JJ; Costentin J
Eur J Pharmacol; 1992 Jan; 210(1):77-84. PubMed ID: 1350989
[TBL] [Abstract][Full Text] [Related]
16. Binding characteristics of the dopamine uptake inhibitor [3H]nomifensine to striatal membranes.
Dubocovich ML; Zahniser NR
Biochem Pharmacol; 1985 Apr; 34(8):1137-44. PubMed ID: 3158318
[TBL] [Abstract][Full Text] [Related]
17. Interaction of two sulfhydryl reagents with a cation recognition site on the neuronal dopamine carrier evidences small differences between [3H]GBR 12783 and [3H]cocaine binding sites.
Refahi-Lyamani F; Saadouni S; Costentin J; Bonnet JJ
Naunyn Schmiedebergs Arch Pharmacol; 1995 Feb; 351(2):136-45. PubMed ID: 7770096
[TBL] [Abstract][Full Text] [Related]
18. Specific binding of [3H]GBR 12783 to the dopamine neuronal carrier included in polarized membranes.
Billaud G; Costentin J; Bonnet JJ
Eur J Pharmacol; 1993 Nov; 247(3):333-40. PubMed ID: 8307105
[TBL] [Abstract][Full Text] [Related]
19. Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+.
Bonnet JJ; Benmansour S; Amejdki-Chab N; Costentin J
Eur J Pharmacol; 1994 Jan; 266(1):87-97. PubMed ID: 8137886
[TBL] [Abstract][Full Text] [Related]
20. [3H]GBR 12935 binding in vivo in mouse brain: labelling of a piperazine acceptor site.
Andersen PH; Jansen JA; Nielsen EB
Eur J Pharmacol; 1987 Nov; 144(1):1-6. PubMed ID: 3436357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
